Core Scientific Inc. (CORZ)
NASDAQ: CORZ · Finance Services · Dover, DE
Our rating: Cautious
Cautious reaffirmed at $11.76, high conviction, November 6, 2026.
Breaks if: The Cautious call would require a full revisit if Core Scientific reports positive free cash flow for two consecutive quarters within the next twelve months — that would indicate the HPC/AI pivot is generating real cash rather than market hope. Alternatively, if reported revenue growth turns positive year-over-year by the second quarter of fiscal 2027, it would signal the revenue erosion has reversed and the transformation is gaining traction. A sustained move above $17 (roughly 45% above today's $11.76) within six months, accompanied by improving reported fundamentals, would also challenge the thesis. None of these conditions is currently met.
Key figures
| Market value | $3.7B |
|---|---|
| Revenue, last 12 months | $592M |
| Net income, last 12 months | −$108M |
| Free cash flow, last 12 months | −$1.3B |
| Price to earnings | n/a |
| Free cash flow yield | −36.2% |
| Dividend yield | 0.0% |
| Operating margin | −73.3% |
| Return on equity | n/a |
| Beta to the S&P 500 | 2.49 |
| Volatility, annualized | 85.4% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| September 30, 2026 | $233M | 187.1% | $0.47 | −$475M |
| June 30, 2026 | $164M | 108.8% | $-3.32 | −$584M |
| March 31, 2026 | $115M | 44.9% | $-1.06 | −$139M |
| December 31, 2025 | $80M | −16.0% | $0.60 | −$122M |
| September 30, 2025 | $81M | −14.9% | $-0.45 | −$113M |
| June 30, 2025 | $79M | −44.3% | $-0.04 | −$87M |
| March 31, 2025 | $80M | −55.6% | $1.24 | −$129M |
| December 31, 2024 | $95M | −33.1% | $-0.69 | −$15M |
Three-model forecasts for the next quarter
Written November 21, 2026, before the report. Each settles from the SEC filing.
- Revenue for the quarter is at least $0.14B: Claude 82%, Gemini 95%, Mistral 90%
- Diluted earnings per share are at least $0.60: Claude 28%, Gemini 35%, Mistral 45%
- Free cash flow for the quarter is above zero: Claude 8%, Gemini 5%, Mistral 10%
36 ledger entries and 64 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.